newli
avail
molecular
tool
allow
sensit
detect
broad
panel
virus
respiratori
tract
specimen
present
studi
applic
multiplex
rtpcr
dna
microarray
diagnosi
epidemiolog
survey
viral
infect
infant
hospit
bronchiol
assess
one
hundr
thirtyeight
nasopharyng
aspir
collect
octob
septemb
test
direct
immunofluoresc
viral
cultur
combin
referenc
rtpcr
dna
microarray
one
virus
detect
specimen
direct
immunofluoresc
viral
cultur
rtpcr
dna
microarray
respect
vs
vs
p
rtpcr
dna
microarray
yield
concord
result
specimen
identifi
mix
viral
infect
common
associ
human
bocaviru
respiratori
syncyti
viru
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
type
respiratori
syncyti
viru
none
bronchiol
sever
paramet
includ
intens
care
unit
admiss
suppli
satur
percentag
length
length
stay
hospit
appear
significantli
increas
multipl
viral
infect
compar
singl
viral
infect
p
conclus
use
dna
microarray
clinic
virolog
practic
allow
rapid
accur
identif
common
uncommon
viral
respiratori
pathogen
infant
hospit
bronchiol
improv
clinic
manag
epidemiolog
survey
prevent
nosocomi
transmiss
respiratori
virus
pediatr
ward
bronchiol
common
distress
potenti
lifethreaten
respiratori
condit
affect
infant
hospit
admiss
rate
usa
europ
bronchiol
report
around
per
children
younger
month
rate
increas
significantli
past
year
smyth
openshaw
hospit
admiss
requir
infant
moder
diseas
mucu
obstruct
interfer
feed
may
induc
apnoea
sever
case
hypoxia
respiratori
distress
may
requir
mechan
ventil
wainwright
bronchiol
import
manifest
viral
respiratori
tract
infect
larg
varieti
viral
pathogen
recogn
implic
major
hospit
case
jacqu
et
al
mahoni
marguet
et
al
wainwright
previou
studi
show
human
respiratori
syncyti
viru
hrsv
picornavirus
enteroviru
ev
rhinoviru
hrv
lead
etiolog
caus
bronchiol
cohort
french
children
present
acut
respiratori
patholog
includ
acut
wheez
ill
bronchiol
asthma
jacqu
et
al
jacqu
et
al
frobert
et
al
human
metapneumoviru
hmpv
parainfluenza
viru
piv
coronaviru
hcov
human
bocaviru
hbov
also
frequent
detect
franc
acut
bronchiol
hospit
children
well
commun
jacqu
et
al
marguet
et
al
freymuth
et
al
regard
diagnosi
respiratori
tract
infect
virolog
laboratori
tradit
use
direct
immunofluoresc
assay
viru
isol
cell
cultur
jartti
et
al
smyth
openshaw
mahoni
howev
limit
scope
throughput
convent
viral
detect
method
mani
bronchiol
case
neg
routin
virolog
diagnosi
mahoni
develop
new
molecular
assay
base
differ
technolog
allow
sensit
detect
broader
panel
virus
respiratori
tract
specimen
li
et
al
mahoni
renoi
et
al
frobert
et
al
ginocchio
among
new
molecular
tool
new
system
base
multiplex
rtpcr
assay
follow
low
densiti
microarray
analysi
develop
recent
evalu
limit
number
clinic
sampl
taken
hospit
infant
frobert
et
al
ginocchio
new
assay
could
allow
rapid
detect
type
subtyp
identif
broad
panel
common
newli
identifi
respiratori
virus
frobert
et
al
ginocchio
could
also
improv
clinic
manag
infant
prevent
nosocomi
transmiss
pediatr
ward
allow
develop
new
epidemiolog
survey
system
respiratori
viral
infect
david
et
al
aim
studi
evalu
analyt
clinic
perform
european
commun
ce
vitro
diagnosi
ivd
mark
commerci
avail
multiplex
rtpcr
dna
microarray
clart
pneumovir
kit
genomica
sau
madrid
spain
allow
rapid
simultan
detect
dna
rna
human
respiratori
virus
clinic
specimen
one
hundr
thirtyeight
children
sex
ratio
mf
hospit
pediatr
depart
reim
univers
medic
centr
franc
octob
septemb
prospect
select
demonstr
clinic
sign
bronchiol
accord
french
consensu
confer
month
old
mean
age
month
sd
ae
admit
pediatr
unit
within
day
symptom
onset
david
et
al
nasopharyng
aspir
sampl
collect
admiss
routin
address
virolog
laboratori
respiratori
virus
detect
direct
immunofluoresc
viru
isol
cell
cultur
divid
aliquot
store
process
multiplex
rtpcr
dna
microarray
sever
bronchiol
retrospect
analyz
use
set
five
classic
criteria
includ
intens
care
unit
admiss
suppli
satur
percentag
puls
oxymetri
hospit
admiss
length
length
stay
hospit
marguet
et
al
inform
consent
obtain
infant
famili
present
studi
conduct
univers
medic
hospit
reim
champagn
ardenn
franc
approv
hospit
ethic
committe
direct
immunofluoresc
assay
detect
hrsv
b
influenza
b
piv
adenoviru
adv
antigen
carri
previous
describ
bouscambert
et
al
jacqu
et
al
two
hundr
microlit
specimen
inocul
duplic
onto
plate
cover
monolay
human
diploid
fibroblast
rhesu
monkey
kidney
madindarbi
canin
kidney
mdck
cell
previous
describ
bouscambert
et
al
viru
isol
type
direct
immunofluoresc
infect
cell
monolay
hrsv
b
influenza
virus
piv
adv
convent
neutral
assay
ev
melnick
et
al
bouscambert
et
al
multiplex
rtpcr
dna
microarray
clart
clinic
array
technolog
pneumovir
kit
genomica
base
viral
genomespecif
fragment
amplif
locat
bp
multiplex
pcr
subsequ
detect
via
hybrid
microorganismspecif
bind
probe
lowdens
microarray
allow
simultan
detect
identif
type
subtyp
human
respiratori
virus
influenza
includ
season
strain
influenza
b
influenza
c
parainfluenza
hrsv
b
human
rhinovirus
adenovirus
ev
speci
b
human
bocaviru
coronaviru
human
metapneumoviru
b
clinic
sampl
renoi
et
al
frobert
et
al
analys
perform
ml
dnarna
extract
nuclisen
easymag
lyon
franc
eightwel
strip
accord
manufactur
instruct
confirm
result
obtain
dna
microarray
combin
multiplex
monoplex
rt
pcr
perform
use
dnarna
extract
freymuth
et
al
eugeneruellan
et
al
coira
et
al
coira
et
al
et
al
pozo
et
al
gaunt
et
al
chisquar
test
mcnemar
chisquar
test
fisher
exact
test
wilcoxon
ranksum
test
carri
appropri
use
sa
softwar
version
sa
institut
cari
nc
result
consid
statist
signific
twosid
pvalu
order
reduc
total
type
error
statist
analys
bronchiol
sever
paramet
n
consid
signific
twosid
pvalu
multivari
analys
perform
use
stepwis
logist
regress
select
variabl
independ
associ
virusrel
sever
case
result
consid
statist
signific
twosid
pvalu
one
potenti
caus
viral
agent
detect
nasopharyng
aspir
sampl
combin
direct
immunofluoresc
viru
cultur
rt
pcr
dna
microarray
respect
vs
vs
p
tabl
virus
detect
frequent
dna
microarray
hrsva
hrsvb
hbov
adv
hmpv
ab
hrv
ev
tabl
ii
eightyf
mix
infect
identifi
eightyfour
confirm
referenc
rtpcr
assay
tabl
tabl
ii
show
detect
rate
distribut
singl
multipl
respiratori
infect
studi
infant
use
dna
microarray
common
associ
hbov
hrsvab
adv
hrsva
b
hrsvab
adv
hbov
tabl
ii
final
viru
posit
infant
hospit
bronchiol
demonstr
singl
viral
respiratori
tract
infect
wherea
infect
one
respiratori
viru
vs
p
tabl
use
dna
microarray
season
pattern
examin
circul
convent
nonconvent
viral
strain
respons
respiratori
tract
infect
infant
hospit
bronchiol
studi
period
novemb
februari
observ
classic
epidem
circul
hrsvab
strain
concomitantli
common
respiratori
virus
adv
strain
period
observ
concomit
epidem
circul
hbov
hmpvab
hrv
ev
addit
endem
circul
adv
peak
hbov
infect
observ
mayjun
fig
influenc
viral
type
impact
mix
viral
infect
bronchiol
sever
analyz
tabl
iii
none
sever
paramet
appear
significantli
increas
case
multipl
viral
respiratori
tract
infect
compar
observ
case
singl
viral
respiratori
tract
infect
p
tabl
iii
infant
infect
hrsv
appear
stay
hospit
comparison
infant
infect
virus
p
tabl
iii
hrsv
posit
infant
younger
hrsv
neg
case
ae
vs
ae
month
p
stay
hospit
relat
age
studi
infant
p
shown
multivari
analysi
adjust
age
indic
signific
increas
length
stay
hospit
ae
day
p
infant
infect
hrsvab
shown
viru
combin
virus
appear
signific
impact
classic
bronchiol
sever
paramet
p
shown
use
clart
pneumovir
kit
retrospect
screen
respiratori
virus
nasopharyng
aspir
sampl
taken
cohort
infant
hospit
bronchiol
northern
franc
full
year
epidemiolog
survey
perform
two
recent
public
describ
use
dna
microarray
studi
respiratori
virus
hospit
infant
admit
intens
care
unit
well
pediatr
adult
patient
influenzalik
ill
renoi
et
al
frobert
et
al
current
studi
compar
first
time
result
obtain
dna
microarray
convent
virolog
method
direct
immunofluoresc
viru
isol
rt
pcr
detect
respiratori
virus
unlik
rt
pcr
dna
microarray
display
similar
perform
detect
virus
except
suggest
lower
sensit
regard
detect
strain
tabl
expect
global
detect
rate
appear
higher
dna
microarray
compar
obtain
classic
techniqu
vs
p
even
common
respiratori
virus
vs
p
tabl
result
could
explain
larg
number
viru
speci
serotyp
subtyp
detect
dna
microarray
well
high
sensit
rang
copi
viral
genom
per
amplif
tube
coira
et
al
coira
et
al
renoi
et
al
viral
detect
rate
compar
publish
recent
studi
use
multiplex
detect
respiratori
virus
report
viral
identif
rang
bronchiol
case
heymann
et
al
choi
et
al
mahoni
marguet
et
al
stempel
et
al
lower
number
hrv
infect
evidenc
present
work
dna
microarray
rt
pcr
could
explain
distinct
made
rhinovirus
ev
infect
often
report
uniqu
picornaviru
group
mahoni
ginocchio
furthermor
sensit
defect
regard
hrvc
detect
molecular
tool
use
could
rule
investig
besid
dna
microarray
abl
identifi
mix
respiratori
tract
infect
wherea
none
detect
convent
respiratori
viru
detect
assay
tabl
ii
rate
multipl
respiratori
tract
infect
appear
higher
previous
publish
report
mix
infect
heymann
et
al
choi
et
al
marguet
et
al
stempel
et
al
find
confirm
use
rt
pcr
like
due
fals
posit
result
rather
low
viral
load
detect
level
classic
techniqu
previous
estim
virus
per
ml
nasopharyng
aspir
kuyper
et
al
interestingli
case
hrsva
adv
infect
identifi
classic
techniqu
could
consid
viral
load
level
equal
superior
virus
per
ml
nasopharyng
aspir
sampl
viral
strain
could
consid
predomin
respiratori
viral
pathogen
even
case
mix
infect
identifi
rtpcr
assay
tabl
ii
although
diagnost
valu
viral
load
nasopharyng
aspir
remain
unclear
quantit
respiratori
virus
may
provid
import
inform
role
viral
pathogen
singl
multipl
respiratori
tract
infect
kuyper
et
al
present
report
dna
microarray
qualit
thu
influenc
viral
load
diseas
sever
could
analyz
henc
case
mix
viral
respiratori
tract
infect
specif
virus
detect
classic
techniqu
neither
possibl
determin
viru
predomin
could
consid
etiolog
agent
demonstr
whether
viru
detect
could
link
begin
ongo
past
viral
respiratori
tract
infect
noksokoivisto
et
al
kuyper
et
al
mahoni
present
studi
screen
larg
panel
respiratori
virus
use
multiplex
rtpcr
dna
microarray
appear
major
epidemiolog
interest
monitor
circul
virus
respons
bronchiol
hospit
infant
approach
confirm
sever
virus
hbov
hrv
adv
hmpvab
could
frequent
detect
tabl
papadopoulo
et
al
jartti
et
al
et
al
jacqu
et
al
pozo
et
al
mahoni
addit
classic
epidem
circul
hrsvab
winter
season
dna
microarray
show
concomit
epidem
circul
adv
hbov
hmpvab
hrv
ev
result
mix
rti
detect
addit
epidemiolog
survey
conduct
year
confirm
spring
peak
hbov
infect
detect
use
convent
techniqu
fig
use
result
obtain
dna
microarray
influenc
viru
speci
impact
mix
viral
infect
bronchiol
sever
analyz
tabl
iii
statist
analys
reveal
none
bronchiol
sever
criteria
significantli
increas
case
mix
infect
compar
singl
infect
specif
viral
combin
associ
sever
diseas
tabl
iii
find
agreement
previou
studi
report
dual
hmpv
hrsv
infect
confer
increas
risk
admiss
pediatr
intens
care
unit
sempl
et
al
richard
et
al
stempel
et
al
result
present
could
explain
low
proport
prematur
newborn
low
rate
hmpv
infect
detect
howev
previous
report
infant
infect
hrsv
stay
longer
hospit
marguet
et
al
suggest
hrsv
might
aggress
viral
agent
bronchiol
infant
younger
month
marguet
et
al
given
larg
panel
multipl
viral
infect
detect
present
studi
tabl
ii
multicent
studi
necessari
assess
whether
specif
viral
associ
could
confer
elev
risk
sever
bronchiol
regard
practic
aspect
analysi
perform
dna
microarray
could
done
total
nucleic
acid
extract
aliquot
clinic
specimen
time
requir
complet
extract
nuclisen
easymag
instrument
lyon
franc
approxim
min
sampl
run
time
amplif
multiplex
rtpcr
hr
time
perform
hybrid
pcr
product
hr
microarray
scan
test
carri
within
min
summari
total
time
complet
assay
approxim
hr
specimen
extract
microarray
detect
allow
therebi
laboratori
provid
answer
clinician
singl
work
day
conclus
use
multiplex
rtpcr
dna
microarray
system
clinic
virolog
practic
allow
rapid
accur
identif
common
uncommon
viral
respiratori
pathogen
infant
hospit
bronchiol
improv
clinic
manag
epidemiolog
survey
prevent
nosocomi
transmiss
respiratori
virus
pediatr
ward
indebt
physician
prospect
includ
children
present
studi
